Literature DB >> 7473885

Spatial distribution of omega-agatoxin IVA binding sites in mouse brain slices.

S Nakanishi1, A Fujii, T Kimura, S Sakakibara, K Mikoshiba.   

Abstract

A peptide toxin derived from funnel-web spider venom, omega-agatoxin IVA, blocks voltage-sensitive calcium channels. Many pharmacological and electrophysiological studies have shown that these channels are widely distributed in both the central nervous system (CNS) and neuromuscular junctions. However, a direct morphological demonstration of the binding sites of this toxin is still lacking. To identify which cells have the binding sites, a biologically active, biotin-conjugated omega-agatoxin IVA was applied to mouse cerebellar and hippocampal slices. Confocal microscopy revealed that omega-agatoxin IVA binding sites were distributed on the somata of Purkinje cells, cerebellar granule cells and interneurons, as well as on the dendrites of Purkinje cells. In the hippocampus, the binding sites were localized on the somata of pyramidal cells of the CA1-CA4 region and on the somata of granule cells in the dentate gyrus. A sequential competitive reaction confirmed the specificity of the binding in the cerebellum and CA1 pyramidal cells, and also suggested a difference in the binding affinity between CA1 and CA3 pyramidal cells. Since a high concentration of omega-agatoxin IVA (2 microM) was needed for the present study, the omega-agatoxin IVA binding sites presented in this study may represent "P-type" and "Q-type" calcium channels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473885     DOI: 10.1002/jnr.490410413

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  2 in total

1.  Differential contribution of L-, N-, and P/Q-type calcium channels to [Ca2+]i changes evoked by kainate in hippocampal neurons.

Authors:  Ana R Santiago; Caetana M Carvalho; Arsélio P Carvalho; António F Ambrósio
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

2.  Voltage-gated calcium channel antagonists and traumatic brain injury.

Authors:  Gene Gurkoff; Kiarash Shahlaie; Bruce Lyeth; Robert Berman
Journal:  Pharmaceuticals (Basel)       Date:  2013-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.